Patent details

Basic Information

Publication number:

EP4048260

PCT Application Number:

US2020056439

Type:

European Patent Granted for LU

Legal Status:

Unitary Effect Registered

Application number:

EP208075614

PCT Publication Number:

WO2021080955

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR USE IN TREATING A HEMATOLOGICAL MALIGNANCY

French Title of Invention:

COMBINAISON COMPRENANT DES COMPOSÉS 4-AMINOISOINDOLINE-1,3-DIONE SUBSTITUÉS ET UN SECOND AGENT ACTIF POUR SON UTILISATION DANS LE TRAITEMENT D'UNE MALIGNITÉ HÉMATOLOGIQUE

German Title of Invention:

KOMBINATION SUBSTITUIERTEN 4-AMINOISOINDOLIN-1,3-DIONVERBINDUNGEN UND ZWEITEN WIRKSTOFFE ZUR VERWENDUNG BEI DER BEHANDLUNG EINER HÄMATOLOGISCHEN MALIGNITÄT

SPC Number:

Unitary Effect

Unitary Effect Requested:

Yes

Unitary Effect Request Filing Date:

07/04/2026

Link to UPP Register:

European Patent Register

Unitary Effect Request Withdrawal Date:

Unitary Effect Status:

Unitary Effect Registered

Unitary Effect Acceptance Decision Date:

17/04/2026

Unitary Effect Rejection Decision Date:

Unitary Effect Date:

11/03/2026

Unitary Effect Registration Date:

17/04/2026

Unitary Effect Re-establishment of rights Filing Date:

Unitary Effect Re-establishment of rights EPO Decision :

Unitary Effect Re-establishment of rights EPO Decision Date:

Explanatory Text UE:

Safety Net Request Date:

Safety Net Decision Date:

Safety Net Decision Outcome:

SPC Number:

Dates

Filing date:

20/10/2020

Grant date:

11/03/2026

EP Publication Date:

31/08/2022

PCT Publication Date:

29/04/2021

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/03/2026

EP B1 Publication Date:

11/03/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

20/10/2040

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/03/2026

 

 

Name:

Celgene Corporation

Address:

Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:

BUCHHOLZ, Tonia J.

Address:

United States (US)

2

Name:

ANTON, Maria Soraya Carrancio

Address:

United States (US)

3

Name:

POURDEHNAD, Michael

Address:

United States (US)

4

Name:

CHANG, Henry

Address:

United States (US)

5

Name:

LOPEZ-GIRONA, Antonia

Address:

United States (US)

6

Name:

PIERCEALL, William Edward

Address:

United States (US)

7

Name:

NARLA, Rama Krishna

Address:

United States (US)

8

Name:

FILVAROFF, Ellen

Address:

United States (US)

9

Name:

KASIBHATLA, Shailaja

Address:

United States (US)

10

Name:

MOHAN, Adithi

Address:

United States (US)

11

Name:

THAKURTA, Anjan

Address:

United States (US)

Priority

Priority Number:

201962923945 P

Priority Date:

21/10/2019

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4045; A61K 31/4184; A61K 31/436; A61K 31/4468; A61K 31/47; A61K 31/506; A61K 31/519; A61K 31/52; A61K 31/5377; A61K 31/55; A61K 31/551; A61K 31/635; A61K 31/675; A61K 31/706; A61K 31/7076; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:

202611

Publication date:

11/03/2026

Description:

Grant (B1)

2

Issue number:

202620

Publication date:

13/05/2026

Description:

Unitary Effect Request Receipt

3

Issue number:

202621

Publication date:

20/05/2026

Description:

Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages